Branded Drug Cos. Paying Off Generics: FTC Report
Spurred by a series of recent legal victories, brand-name drug makers are increasingly collaborating with generic rivals to stall the introduction of cheaper generic drugs to the detriment of consumers, according...To view the full article, register now.
Already a subscriber? Click here to view full article